• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谁是典型的迷幻药使用者?迷幻药使用及其后果研究中的方法学挑战。

Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences.

作者信息

Johnstad Petter Grahl

机构信息

University of Bergen, Norway.

出版信息

Nordisk Alkohol Nark. 2021 Feb;38(1):35-49. doi: 10.1177/1455072520963787. Epub 2020 Oct 20.

DOI:10.1177/1455072520963787
PMID:35309094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8899058/
Abstract

AIMS

This article argues that despite a resurgence in research on psychedelics over the last two decades, we still have little insight into the psychedelics user population. Furthermore, there is currently little agreement between researchers as to the long-term mental health consequences of psychedelics use.

DESIGN

In a methodological review of a range of studies in psychedelics use, it is demonstrated that these studies tend to focus on specific segments of the user population while excluding others. These population segments are probably connected to different patterns of use, which in turn are likely to result in different long-term consequences.

RESULTS

The divergent findings on the consequences of psychedelics use may be explained, at least in part, by the fact that different research strategies explore different segments of the user population. Studies focusing on user segments with problematic usage patterns tend to find that psychedelics use is negative for mental health, while studies on infrequent users tend to find that psychedelics use is positive for mental health.

CONCLUSION

Because the field of psychedelics studies lacks a reliable model of the user population, it is difficult for researchers to contextualise and assess the broader validity of their findings. To remedy this situation, the article presents three theoretical models of the user population that afford us with tentative means of contextualising findings and thereby may clarify present disagreements.

摘要

目标

本文认为,尽管在过去二十年里,对迷幻剂的研究再度兴起,但我们对迷幻剂使用者群体仍知之甚少。此外,目前研究人员对于使用迷幻剂对长期心理健康的影响尚未达成共识。

设计

在对一系列迷幻剂使用研究的方法学综述中,表明这些研究倾向于关注使用者群体的特定部分,而排除其他部分。这些人群部分可能与不同的使用模式相关,而这反过来又可能导致不同的长期后果。

结果

关于使用迷幻剂后果的不同研究结果,至少部分可以通过不同的研究策略探索使用者群体的不同部分这一事实来解释。关注有问题使用模式的使用者群体的研究往往发现,使用迷幻剂对心理健康有负面影响,而对不常使用者的研究则往往发现,使用迷幻剂对心理健康有积极影响。

结论

由于迷幻剂研究领域缺乏可靠的使用者群体模型,研究人员难以将其研究结果置于具体情境中并评估其更广泛的有效性。为了纠正这种情况,本文提出了三种使用者群体的理论模型,为我们提供了将研究结果置于具体情境中的初步方法,从而可能澄清目前的分歧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba32/8899058/184f7fded9a4/10.1177_1455072520963787-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba32/8899058/2f909bf579c5/10.1177_1455072520963787-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba32/8899058/f99b69ee8bcc/10.1177_1455072520963787-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba32/8899058/184f7fded9a4/10.1177_1455072520963787-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba32/8899058/2f909bf579c5/10.1177_1455072520963787-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba32/8899058/f99b69ee8bcc/10.1177_1455072520963787-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba32/8899058/184f7fded9a4/10.1177_1455072520963787-fig3.jpg

相似文献

1
Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences.谁是典型的迷幻药使用者?迷幻药使用及其后果研究中的方法学挑战。
Nordisk Alkohol Nark. 2021 Feb;38(1):35-49. doi: 10.1177/1455072520963787. Epub 2020 Oct 20.
2
Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the COVID-19 pandemic.在新冠疫情期间,使用迷幻剂及其他消遣性药物与心理健康和恢复力之间的关联。
Front Psychiatry. 2023 Jun 15;14:1184681. doi: 10.3389/fpsyt.2023.1184681. eCollection 2023.
3
Psychedelics and mental health: a population study.迷幻剂与心理健康:一项人群研究。
PLoS One. 2013 Aug 19;8(8):e63972. doi: 10.1371/journal.pone.0063972. eCollection 2013.
4
Positive psychology in the investigation of psychedelics and entactogens: A critical review.积极心理学在迷幻剂和致幻剂研究中的应用:批判性评价。
Neuropharmacology. 2018 Nov;142:179-199. doi: 10.1016/j.neuropharm.2018.06.034. Epub 2018 Jun 30.
5
What can neuroscience tell us about the potential of psychedelics in healthcare? How the neurophenomenology of psychedelics research could help us to flourish throughout our lives, as well as to enhance our dying.神经科学能告诉我们关于迷幻药在医疗保健方面的潜力有哪些?迷幻药研究的神经现象学如何能帮助我们一生都蓬勃发展,以及改善我们临终时的状况。
Curr Drug Abuse Rev. 2014;7(3):136-45. doi: 10.2174/1874473708666150107114927.
6
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.经典迷幻剂:流行病学、治疗学、神秘体验和大脑网络功能的综合综述。
Pharmacol Ther. 2019 May;197:83-102. doi: 10.1016/j.pharmthera.2018.11.010. Epub 2018 Dec 4.
7
Microdosing psychedelics: Motivations, subjective effects and harm reduction.微剂量使用迷幻剂:动机、主观效应和减少危害。
Int J Drug Policy. 2020 Jan;75:102600. doi: 10.1016/j.drugpo.2019.11.008. Epub 2019 Nov 25.
8
[Efficacy of psychedelics in psychiatry, a systematic review of the literature].[迷幻剂在精神病学中的疗效:文献系统综述]
Encephale. 2021 Aug;47(4):376-387. doi: 10.1016/j.encep.2020.12.002. Epub 2021 Apr 20.
9
User profiles and personas in the design and development of consumer health technologies.用户画像和角色在消费者健康技术的设计和开发中的应用。
Int J Med Inform. 2013 Nov;82(11):e251-68. doi: 10.1016/j.ijmedinf.2011.03.006. Epub 2011 Apr 9.
10
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers.迷幻剂的娱乐性使用与人格特质开放性升高有关:对与大脑血清素标志物的关联的探索。
J Psychopharmacol. 2019 Sep;33(9):1068-1075. doi: 10.1177/0269881119827891. Epub 2019 Feb 28.

引用本文的文献

1
Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms.心理创伤症状个体对创伤治疗、自我管理策略以及迷幻疗法态度的观点
Psychiatry Clin Psychopharmacol. 2025 Jul 30;35(Suppl 1):S3-S19. doi: 10.5152/pcp.2025.24934.
2
Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress.迷幻剂对污名和痛苦的调节关系中的种族和性别差异
Psychedelic Med (New Rochelle). 2025 May 26;3(2):71-80. doi: 10.1089/psymed.2024.0021. eCollection 2025 Jun.
3
The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress.

本文引用的文献

1
Are ecstasy induced serotonergic alterations overestimated for the majority of users?大多数使用者的 5-羟色胺能改变是否被摇头丸夸大了?
J Psychopharmacol. 2018 Jul;32(7):741-748. doi: 10.1177/0269881118767646. Epub 2018 May 7.
2
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.心理支持辅助下的致幻蘑菇治疗难治性抑郁症:6 个月随访。
Psychopharmacology (Berl). 2018 Feb;235(2):399-408. doi: 10.1007/s00213-017-4771-x. Epub 2017 Nov 8.
3
Long-lasting subjective effects of LSD in normal subjects.
医疗保健可及性、性别与迷幻剂之间的关系及其对痛苦的影响。
Healthcare (Basel). 2025 May 16;13(10):1158. doi: 10.3390/healthcare13101158.
4
Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users.自然主义迷幻药使用者样本中的迷幻疗法治疗师性行为不端及其他不良经历
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):41-47. doi: 10.1089/psymed.2024.0011. eCollection 2025 Mar.
5
Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.经典迷幻药和 MDMA 的急性和亚急性效应与认知功能的关联:系统综述和荟萃分析。
Sci Rep. 2024 Jun 26;14(1):14782. doi: 10.1038/s41598-024-65391-9.
6
Psychotomimetic compensation versus sensitization.精神拟态补偿与敏化。
Pharmacol Res Perspect. 2024 Aug;12(4):e1217. doi: 10.1002/prp2.1217.
7
Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians.少数族裔迷幻体验回报减少:收入和教育程度对白人、黑人、西班牙裔和亚裔的影响
J Racial Ethn Health Disparities. 2025 Jun;12(3):1937-1950. doi: 10.1007/s40615-024-02023-y. Epub 2024 May 16.
8
Subjective long-term emotional and social effects of recreational MDMA use: the role of setting and intentions.娱乐性使用摇头丸的主观长期情绪和社会影响:环境和意图的作用。
Sci Rep. 2024 Feb 10;14(1):3434. doi: 10.1038/s41598-024-51355-6.
9
Pattern breaking: a complex systems approach to psychedelic medicine.模式突破:迷幻药医学的复杂系统方法
Neurosci Conscious. 2023 Jul 6;2023(1):niad017. doi: 10.1093/nc/niad017. eCollection 2023.
10
The association between naturalistic use of psychedelics and co-occurring substance use disorders.迷幻剂的自然使用与并发物质使用障碍之间的关联。
Front Psychiatry. 2023 Jan 10;13:1066369. doi: 10.3389/fpsyt.2022.1066369. eCollection 2022.
正常受试者中 LSD 的持久主观效应。
Psychopharmacology (Berl). 2018 Feb;235(2):535-545. doi: 10.1007/s00213-017-4733-3. Epub 2017 Sep 16.
4
Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness.使用(经典)迷幻剂的终生经历通过增强与自然的联系来预测亲环境行为。
J Psychopharmacol. 2017 Aug;31(8):975-988. doi: 10.1177/0269881117714049. Epub 2017 Jun 20.
5
Psychedelics, Personality and Political Perspectives.迷幻剂、个性与政治观点。
J Psychoactive Drugs. 2017 Jul-Aug;49(3):182-191. doi: 10.1080/02791072.2017.1312643. Epub 2017 Apr 26.
6
The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.迷幻药物的治疗潜力:过去、现在和未来。
Neuropsychopharmacology. 2017 Oct;42(11):2105-2113. doi: 10.1038/npp.2017.84. Epub 2017 Apr 26.
7
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.裸盖菇素可使患有危及生命癌症的患者的抑郁和焦虑症状大幅且持续减轻:一项随机双盲试验。
J Psychopharmacol. 2016 Dec;30(12):1181-1197. doi: 10.1177/0269881116675513.
8
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.裸盖菇素治疗危及生命的癌症患者焦虑和抑郁后症状快速且持续缓解:一项随机对照试验
J Psychopharmacol. 2016 Dec;30(12):1165-1180. doi: 10.1177/0269881116675512.
9
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.服用裸盖菇素蘑菇后挑战性经历的调查研究:急性和持久的积极与消极后果
J Psychopharmacol. 2016 Dec;30(12):1268-1278. doi: 10.1177/0269881116662634. Epub 2016 Aug 30.
10
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.裸盖菇素联合心理支持治疗难治性抑郁症:一项开放标签可行性研究。
Lancet Psychiatry. 2016 Jul;3(7):619-27. doi: 10.1016/S2215-0366(16)30065-7. Epub 2016 May 17.